A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

Journal of Experimental Medicine

Volumn 180, Issue 1, 1994, Pages 35-42

  Coulie, Pierre G ^a   Brichard, Vincent ^a   Van Pel, Aline ^a   Wolfel, Thomas ^b   Schneider, Jörg ^b   Traversari, Catia ^c   Mattei, Stes ^c   De Plaen, Etienne ^a   Lurquin, Christophe ^a   Szikora, Jean Pierre ^a   Renauld, Jean Christophe ^a   Boon, Thierry ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION ANTIGEN; HLA A2 ANTIGEN; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXON; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; DNA, COMPLEMENTARY; GENE EXPRESSION; HLA-A2 ANTIGEN; HUMAN; MELANOMA; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0028303166     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.1.35     Document Type: Article

References (28)

1. Mukherji, B., and T.J. MacAlister. 1983. Clonal analysis of cytotoxic T cell response against human melanoma. J. Exp. Med. 158:240.
2. Fossati, G., D. Taramelli, A. Balsari, G. Bogdanovich, S. An-dreola, and G. Parmiani. 1984. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int. J. Cancer. 33:591.
3. Knuth, A., B. Danowski, H.F. Oettgen, and L. Old. 1984. T-cell mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc. Natl. Acad. Sci. USA. 81:3511.
4. Hérin, M., C. Lemoine, P. Weynants, F. Vessiére, A. Van Pel, A. Knuth, R. Devos, and T. Boon. 1987. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer. 39:390.
5. Darrow, T.L., C.L. Slingluff, and H.F. Seigler. 1988. Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanomas. Cancer. 62:84.
6. Darrow, T.L., C.L.J. Slingluff, and H.F. Seigler. 1989. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J. Immunol. 142:3329.
7. Kawakami, Y., R. Zakut, S.L. Topalian, H. Stótter, and S.A. Rosenberg. 1992. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J. Immunol. 148:638.
8. Viret, C., F. Davodeau, Y. Guilloux, J.-D. Bignon, G. Semana, R. Breathnach, and F. Jotereau. 1993. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes. Eur. J. Immunol. 23:141.
9. Wolfel, T., M. Hauer, E. Klehmann, V. Brichard, B. Ackermann, A. Knuth, T. Boon, and K.-H. Meyer zum Büschen-felde. 1993. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer. 55:237.
10. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489.
11. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselec-tion procedure. Proc. Natl. Acad. Sci. USA. 84:3365.
12. Karttunen, J., S. Sanderson, and N. Shastri. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA. 89:6020.
13. Mellon, P., V. Parker, Y. Gluzman, and T. Maniatis. 1981. Identification of DNA sequences required for transcription of the human al-globin gene in a new SV40 host-vector system. Cell. 27:279.
14. Knuth, A., T. Wolfel, E. Klehmann, T. Boon, and K.-H. Meyer zum Büschenfelde. 1989. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA. 86:2804.
15. Wolfel, T, E. Klehmann, C. Müller, K.-H. Schütt, K.-H. Meyer zum Büschenfelde, and A. Knuth. 1989. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J. Exp. Med. 170:797.
16. Espevik, T, and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99.
17. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors. 1993. Current protocols in Molecular Biology. Greene Publishing Associates and John Wiley & Sons, New York.
18. Traversari, C., P. van der Bruggen, B. Van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. lmmunogenetics. 35:145.
19. −) variants of mouse tumor P815: cloning of the gene of turn" antigen P91A and identification of the turn" mutation. Proc. Natl. Acad. Sci. USA. 85:2274.
20. Davis, L.G., M.D. Dibner, and J.F. Battey. 1986. Basic Methods in Molecular Biology. Elsevier Science Publisher, New York. 130.
21. van der Bruggen, P., C. Traversari, P. Chômez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643.
22. CouUe, P.G., P. Weynants, F. Lehmann, J. Herman, V. Brichard, T. Wolfel, A. Van Pel, E. De Plaen, F. Brasseur, and T. Boon. 1993. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J. Immunother. 14:104.
23. Weynants, P., R Lethé, F. Brasseur, M. Marchand, and T. Boon. 1994. Expression of MAGE genes by non-small cell lung carcinomas. Int. J. Cancer. 56:826.
24. Brasseur, F., M. Marchand, R. Vanwijck, M. Hérin, B. Lethé, P. Chômez, and T. Boon. 1992. Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors. Int. J. Cancer. 52:839.
25. Bakker, A.B.H., M.W.J. Schreurs, A.J. deBoer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005.
26. Anichini, A., C. Maccalli, R. Mortarini, S. Salvi, A. Maz-zocchi, P. Squarcina, M. Herlyn, and G. Parmiani. 1993. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177:989.
27. Mattes, M.J., T.M. Thomson, L.J. Old, and K.O. Lloyd. 1983. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int. J. Cancer. 32:717.
28. Vijayasaradhi, S., B. Bouchard, and A.N. Houghton. 1990. The melanoma antigen gp75 is the human homologue of the mouse b (BROWN) locus gene product. J. Exp. Med. 171:1375.